Focus Partners Wealth’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$31.1M Sell
59,480
-2,424
-4% -$1.33M 0.03% 405
2026
Q2
$32.6M Buy
61,904
+1,716
+3% +$962K 0.03% 405
2026
Q1
$33.8M Sell
60,188
-1,201
-2% -$770K 0.04% 373
2025
Q4
$41.4M Buy
61,389
+9,471
+18% +$6.45M 0.05% 330
2025
Q3
$33.2M Buy
51,918
+724
+1% +$439K 0.05% 289
2025
Q2
$27.5M Buy
51,194
+4,363
+9% +$2.09M 0.06% 290
2025
Q1
$19.7M Buy
46,831
+4,255
+10% +$1.85M 0.05% 329
2024
Q4
$17.6M Buy
42,576
+27,830
+189% +$12.2M 0.05% 346
2024
Q3
$4.99M Sell
14,746
-17,813
-55% -$8.65M 0.02% 561
2024
Q2
$15.9M Buy
32,559
+29,444
+945% +$14.8M 0.05% 279
2024
Q1
$1.68M Buy
3,115
+1,605
+106% +$877K 0.01% 514
2023
Q4
$838K Buy
+1,510
New +$709K 0.01% 482

Other funds holding IDXX

Focus Partners Wealth's IDXX Position: Q3 2026 in Review

Focus Partners Wealth reduced its Idexx Laboratories (IDXX) stake by 3.9% in Q3 2026, selling an estimated $1.33M and leaving 59,480 shares worth $31.1M. The position accounts for 0.03% of the portfolio, ranked #405.

Focus Partners Wealth first reported a position in IDXX in Q4 2023 and has held it in 12 quarters since. The position peaked at $41.4M in Q4 2025. 1,276 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Focus Partners Wealth held 59,480 shares of Idexx Laboratories worth $31.1M as of Q3 2026.
  • Focus Partners Wealth sold 2,424 Idexx Laboratories shares in Q3 2026, an estimated $1.33M.
  • Idexx Laboratories made up 0.03% of Focus Partners Wealth's portfolio in Q3 2026, its #405 holding.
  • Focus Partners Wealth first reported a position in Idexx Laboratories in Q4 2023 and has held it in 12 quarters since.
  • Focus Partners Wealth's Idexx Laboratories position peaked at $41.4M in Q4 2025.
  • 1,276 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Focus Partners Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.